CK

Chinnaswamy Kalai Selvi

Active Director Director DIN 09171702
DIN 09171702 First appointment May 2021 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2021
Shareholding value •••• Premium profile

About Chinnaswamy Kalai Selvi

Data last updated:

Chinnaswamy Kalai Selvi is a Director at Medicims Pharma Private Limited (since 2021). The company operates in Trading. Medicims Pharma Private Limited reported revenue of ₹3.32 Cr (FY 2025).

DIN 09171702
Primary Designation Director
Industry Trading
First Appointment 12 May 2021
Oldest Company Age 5 yrs
Largest company Medicims Pharma Private Limited · ₹3.32 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medicims Pharma Private Limited U51909KA2021PTC147344
Director12 May 20212021₹3.32 Cr (FY 2025)Active

Board colleagues of Chinnaswamy Kalai Selvi

Directorship timeline

Open interactive timeline →
Medicims Pharma Private Limited
Premium access

Shareholding and investment profile for Chinnaswamy Kalai Selvi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chinnaswamy Kalai Selvi

Chinnaswamy Kalai Selvi currently holds 1 directorship: Medicims Pharma Private Limited (Director, since 12 May 2021, revenue ₹3.32 Cr (FY 2025)).

Chinnaswamy Kalai Selvi was first appointed on 12 May 2021 as Director at Medicims Pharma Private Limited.

The current boards of Chinnaswamy Kalai Selvi's companies include Devaraj Vadivel (Medicims Pharma Private Limited), Raji Ramadass (Medicims Pharma Private Limited), Vadivel Pandiyaraj (Medicims Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available